伴侶動物骨關節炎市場規模、佔有率和成長分析：按治療類型、動物類型、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球伴侶動物骨關節炎市值為 42.8 億美元，預計到 2025 年將成長至 47 億美元，到 2033 年將成長至 98.5 億美元，在預測期（2026-2033 年）內複合年成長率為 9.7%。

全球伴侶動物骨關節炎市場涵蓋旨在診斷、預防和治療寵物（尤其是犬貓）關節退化性疾病的藥物、營養補充劑和獸醫服務。隨著寵物壽命的延長以及飼主將寵物視為家庭成員，維持寵物活動能力的干預措施需求日益成長。標靶治療的進步和寵物飼主購買力的提升是推動市場成長的主要因素。生物製藥等創新療法在改善步態方面展現出良好的效果，而監測關節疼痛的健康管理平台則提高了治療順從性。人工智慧成像技術透過檢測細微的關節變化和量化炎症，正在革新診斷方式。這簡化了評估流程，加速了精準獸醫學的普及，並擴大了市場滲透率，以滿足寵物飼主不斷變化的需求。

全球伴侶動物骨關節炎市場成長要素

全球伴侶動物骨關節炎市場正在擴張，這主要歸功於寵物飼主日益增強的健康意識，他們更重視犬貓的長期健康。隨著寵物越來越被視為家庭成員，主人積極尋求預防性治療和復健方案，以維持寵物的運動功能並提高其生活品質。這種意識的轉變促使獸醫診所採用更全面的骨關節炎治療方案，從而帶動了對藥品、營養補充劑和輔助器具的需求成長。市場需求的不斷成長刺激了產品開發商的創新，並拓展了通路，同時獸醫也擴大向寵物飼主推薦更先進的護理方案。

全球伴侶動物骨關節炎市場的限制因素

寵物骨關節炎先進治療的高昂費用給寵物飼主帶來了沉重的負擔，尤其是在可支配收入有限的地區。許多寵物飼主難以平衡治療費用與其他經濟負擔，這可能導致治療方案的啟動和持續延誤。這種情況導致治療依從性降低，影響治療的整體效果，並阻礙製造商全面進入市場。這些經濟障礙最終阻礙了市場擴張，使許多潛在患者無法獲得所需的治療。此外，缺乏足夠的保險保障也加劇了這些經濟負擔問題。

伴侶動物骨關節炎的全球市場趨勢

全球伴侶動物骨關節炎市場正經歷著向個人化醫療的重大轉變，獸醫們正採用精準醫療技術，利用基因譜分析和生物標記分析等手段。這一趨勢有助於早期發現骨關節炎，並方便選擇針對每隻寵物生理需求和生活方式量身定做的治療方案。隨著寵物飼主對更有效、更微創治療的需求日益成長，獸醫院正在積極採用先進的影像和分子診斷技術。這些進步正在建立一個協作式醫療生態系統，透過為伴侶動物製定個人化、全面的健康管理策略，從而改善治療效果並增強客戶忠誠度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球伴侶動物骨關節炎市場規模：依治療類型分類

• 藥物治療
  • NSAIDs
  • 單株抗體
  • 其他藥物
• 再生醫學
• 營養補充品
• 復健和物理治療

全球伴侶動物骨關節炎市場規模：依動物類型分類

• 狗
• 貓
• 馬
• 其他

全球伴侶動物骨關節炎市場規模：依通路分類

• 獸醫醫院和診所
• 零售藥房
• 網路藥房

全球伴侶動物骨關節炎市場規模：依最終用戶分類

• 動物醫院
• 動物診所
• 居家照護

全球伴侶動物骨關節炎市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Virbac SA
• Vetoquinol SA
• Dechra Pharmaceuticals PLC
• Merck & Co., Inc.
• Norbrook Laboratories Limited
• Chanelle Pharma Group
• Kindred Biosciences, Inc.
• Heska Corporation
• PetVivo Holdings, Inc.
• Arthramid Vet Systems
• Bioventus LLC
• American Regent Animal Health
• Bimeda, Inc.
• VetPlus Ltd.
• Phibro Animal Health Corporation
• Covetrus, Inc.

結論與建議

Global Companion Animal Osteoarthritis Market size was valued at USD 4.28 Billion in 2024 and is poised to grow from USD 4.7 Billion in 2025 to USD 9.85 Billion by 2033, growing at a CAGR of 9.7% during the forecast period (2026-2033).

The global companion animal osteoarthritis market encompasses pharmaceuticals, nutraceuticals, and veterinary services aimed at diagnosing, preventing, and treating joint degeneration in pets, particularly dogs and cats. As pet longevity increases and owners seek family-like care for their animals, there's a rising demand for interventions that maintain mobility. Market growth has been fueled by advances in targeted therapeutics and heightened spending power among pet owners. Innovative treatments, such as biologics, have shown promise in improving gait, while health platforms for monitoring joint pain enhance treatment adherence. AI-driven imaging technology is revolutionizing diagnosis by detecting subtle joint changes and quantifying inflammation, streamlining assessments and fostering the adoption of precision veterinary medicine, which broadens market penetration in response to the evolving needs of pet owners.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Osteoarthritis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Osteoarthritis Market Segments Analysis

Global companion animal osteoarthritis market is segmented by treatment type, animal type, distribution channel, end user and region. Based on treatment type, the market is segmented into Pharmacological Therapy, Regenerative Therapy, Nutritional Supplements and Rehabilitation & Physical Therapy. Based on animal type, the market is segmented into Dogs, Cats, Horses and Others. Based on distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Home Care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Osteoarthritis Market

The expansion of the Global Companion Animal Osteoarthritis market is significantly influenced by the increasing commitment of pet owners to prioritize the long-term health and wellness of their dogs and cats. As these animals are increasingly viewed as cherished family members, owners are actively seeking preventative treatments and therapeutic solutions to preserve their pets' mobility and enhance their quality of life. This shift in mindset is prompting veterinary clinics to implement more comprehensive osteoarthritis treatment programs, resulting in a higher demand for pharmaceuticals, nutraceuticals, and supportive devices. This growing market interest is sparking innovation among product developers and expanding distribution avenues, while veterinarians are increasingly endorsing advanced care regimens to pet owners.

Restraints in the Global Companion Animal Osteoarthritis Market

The high costs associated with advanced therapies for osteoarthritis in companion animals pose a considerable burden on pet owners, particularly in areas with restricted disposable income. Many pet owners find themselves juggling treatment costs with other financial commitments, which can lead to delays in starting or maintaining prescribed treatment plans. This situation results in decreased compliance, affecting the overall effectiveness of the treatments and discouraging manufacturers from fully entering the market. The financial barrier ultimately hampers market expansion, leaving many potential patients without access to necessary care. Additionally, the lack of adequate insurance coverage exacerbates these affordability issues.

Market Trends of the Global Companion Animal Osteoarthritis Market

The Global Companion Animal Osteoarthritis market is witnessing a significant shift towards personalized therapeutics, as veterinarians adopt precision medicine techniques that harness genetic profiling and biomarker analysis. This trend allows for the early detection of osteoarthritis and facilitates the selection of tailored interventions that cater to the unique physiological needs and lifestyles of pets. As demand for more effective and less invasive treatment options grows among pet owners, clinics are increasingly implementing advanced imaging technologies and molecular diagnostics. This evolution fosters a collaborative care ecosystem, enhancing treatment outcomes and building strong client loyalty through personalized and comprehensive health management strategies for companion animals.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Companion Animal Osteoarthritis Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological Therapy
  • NSAIDs
  • Monoclonal Antibodies
  • Other Pharmaceuticals
• Regenerative Therapy
• Nutritional Supplements
• Rehabilitation & Physical Therapy

Global Companion Animal Osteoarthritis Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Horses
• Others

Global Companion Animal Osteoarthritis Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies

Global Companion Animal Osteoarthritis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Home Care

Global Companion Animal Osteoarthritis Market Size & CAGR (2026-2033)

• North America (Treatment Type, Animal Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Treatment Type, Animal Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Animal Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Animal Type, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Animal Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chanelle Pharma Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetVivo Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthramid Vet Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Regent Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetPlus Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations